» Articles » PMID: 26788464

Baroreflex Dysfunction in Chronic Kidney Disease

Overview
Journal World J Nephrol
Specialty Nephrology
Date 2016 Jan 21
PMID 26788464
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) patients have high cardiovascular mortality and morbidity. The presence of traditional and CKD related risk factors results in exaggerated vascular calcification in these patients. Vascular calcification is associated with reduced large arterial compliance and thus impaired baroreflex sensitivity (BRS) resulting in augmented blood pressure (BP) variability and hampered BP regulation. Baroreflex plays a vital role in short term regulation of BP. This review discusses the normal baroreflex physiology, methods to assess baroreflex function, its determinants along with the prognostic significance of assessing BRS in CKD patients, available literature on BRS in CKD patients and the probable patho-physiology of baroreflex dysfunction in CKD.

Citing Articles

Baroreflex Sensitivity Assessment Using the Sequence Method with Delayed Signals in End-Stage Renal Disease Patients.

Martinez-Alanis M, Calderon-Juarez M, Martinez-Garcia P, Gonzalez Gomez G, Infante O, Perez-Grovas H Sensors (Basel). 2023; 23(1).

PMID: 36616859 PMC: 9823877. DOI: 10.3390/s23010260.


High-Volume Hemodiafiltration and Cool Hemodialysis Have a Beneficial Effect on Intradialytic Hemodynamics: A Randomized Cross-Over Trial of Four Intermittent Dialysis Strategies.

Rootjes P, Chaara S, de Roij van Zuijdewijn C, Nube M, Wijngaarden G, Grooteman M Kidney Int Rep. 2022; 7(9):1980-1990.

PMID: 36090495 PMC: 9459077. DOI: 10.1016/j.ekir.2022.06.021.


Naringin and Trimetazidine Improve Baroreflex Sensitivity and Nucleus Tractus Solitarius Electrical Activity in Renal Ischemia-Reperfusion Injury.

Amini N, Sarkaki A, Dianat M, Mard S, Ahangarpour A, Badavi M Arq Bras Cardiol. 2021; 117(2):290-297.

PMID: 34495221 PMC: 8395798. DOI: 10.36660/abc.20200121.


Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.

Nakano T, Shiizaki K, Miura Y, Matsui M, Kosaki K, Mori S Sci Rep. 2019; 9(1):19247.

PMID: 31848393 PMC: 6917750. DOI: 10.1038/s41598-019-55643-4.


Arterial Stiffness in the Heart Disease of CKD.

Zanoli L, Lentini P, Briet M, Castellino P, House A, London G J Am Soc Nephrol. 2019; 30(6):918-928.

PMID: 31040188 PMC: 6551785. DOI: 10.1681/ASN.2019020117.


References
1.
Shishehbor M, Oliveira L, Lauer M, Sprecher D, Wolski K, Cho L . Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. Am J Cardiol. 2008; 101(12):1741-6. PMC: 3354958. DOI: 10.1016/j.amjcard.2008.02.060. View

2.
Bondia A, Tabernero J, Macias J, Martin-Luengo C . Autonomic nervous system in haemodialysis. Nephrol Dial Transplant. 1988; 3(2):174-80. View

3.
Foley R, Parfrey P, Sarnak M . Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 2001; 9(12 Suppl):S16-23. View

4.
PALMERO H, Caeiro T, Iosa D, Bas J . Baroreceptor reflex sensitivity index derived from Phase 4 of te Valsalva maneuver. Hypertension. 1981; 3(6 Pt 2):II-134-7. DOI: 10.1161/01.hyp.3.6_pt_2.ii-134. View

5.
COLERIDGE H, COLERIDGE J, Poore E, Roberts A, Schultz H . Aortic wall properties and baroreceptor behaviour at normal arterial pressure and in acute hypertensive resetting in dogs. J Physiol. 1984; 350:309-26. PMC: 1199271. DOI: 10.1113/jphysiol.1984.sp015203. View